Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


03.10.2017

4 AJR Am J Roentgenol
1 Am J Gastroenterol
2 Am J Pathol
2 Biochem Biophys Res Commun
1 BMC Cancer
7 Cancer Res
1 Dig Dis Sci
1 Gastrointest Endosc
1 Gut
9 Hepatology
1 Int J Cancer
1 J Comput Assist Tomogr
2 J Gastroenterol
6 J Gastroenterol Hepatol
2 J Hepatol
1 J Pediatr Surg
1 Lancet Oncol
5 Oncogene
1 PLoS Biol
26 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CAMPO CA, Hernando D, Schubert T, Bookwalter CA, et al
    Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    AJR Am J Roentgenol. 2017;209:592-603.
    PubMed     Text format     Abstract available

  2. ISHIKAWA T, Aibe Y, Matsuda T, Iwamoto T, et al
    Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    AJR Am J Roentgenol. 2017;209:W169-W176.
    PubMed     Text format     Abstract available

  3. CORVINO A, Catalano O, Corvino F, Sandomenico F, et al
    Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions.
    AJR Am J Roentgenol. 2017 Jun 22:W1-W9. doi: 10.2214/AJR.16.17062.
    PubMed     Text format     Abstract available

  4. GLAZER DI, Tatli S, Shyn PB, Vangel MG, et al
    Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.
    AJR Am J Roentgenol. 2017 Sep 27:1-9. doi: 10.2214/AJR.16.17582.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  5. STINE JG, Rinella ME
    Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?
    Am J Gastroenterol. 2017;112:752-754.
    PubMed     Text format     Abstract available


    Am J Pathol

  6. CHOWDHARY V, Teng KY, Thakral S, Zhang B, et al
    miR-122 protects mice and human hepatocytes from acetaminophen toxicity by regulating CYP1A2 and CYP2E1 expression.
    Am J Pathol. 2017 Sep 26. pii: S0002-9440(17)30413.
    PubMed     Text format     Abstract available

  7. POZNIAK KN, Pearen MA, Pereira TN, Kramer CS, et al
    Taurocholate induces biliary differentiation of liver progenitor cells causing hepatic stellate cell chemotaxis in the Ductular Reaction: Role in pediatric cystic fibrosis liver disease.
    Am J Pathol. 2017 Sep 18. pii: S0002-9440(17)30375.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  8. LIU LP, Yang M, Peng QZ, Li MY, et al
    UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Biochem Biophys Res Commun. 2017 Sep 18. pii: S0006-291X(17)31862.
    PubMed     Text format     Abstract available

  9. MACHIHARA K, Tanaka H, Hayashi Y, Murakami I, et al
    Questiomycin A stimulates sorafenib-induced cell death via suppression of glucose-regulated protein 78.
    Biochem Biophys Res Commun. 2017;492:33-40.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. PU WY, Zhang R, Xiao L, Wu YY, et al
    Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.
    BMC Cancer. 2016;16:943.
    PubMed     Text format     Abstract available


    Cancer Res

  11. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available

  12. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Text format     Abstract available

  13. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available

  14. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available

  15. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Text format     Abstract available

  16. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Text format     Abstract available

  17. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  18. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  19. MAPLE JT, Pannala R, Abu Dayyeh BK, Aslanian HR, et al
    Interventional EUS (with videos).
    Gastrointest Endosc. 2017;85:465-481.
    PubMed     Text format    


    Gut

  20. ZHOU J, Liu M, Sun H, Feng Y, et al
    Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
    Gut. 2017 Sep 22. pii: gutjnl-2017-314032. doi: 10.1136/gutjnl-2017-314032.
    PubMed     Text format     Abstract available


    Hepatology

  21. KRENKEL O, Puengel T, Govaere O, Abdallah AT, et al
    Therapeutic Inhibition of Inflammatory Monocyte Recruitment Reduces Steatohepatitis and Liver Fibrosis.
    Hepatology. 2017 Sep 21. doi: 10.1002/hep.29544.
    PubMed     Text format     Abstract available

  22. LUO P, Yin P, Hua R, Tan Y, et al
    A large-scale, multi-center serum metabolite biomarkers identification study for the early detection of hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29561.
    PubMed     Text format     Abstract available

  23. TIMCHENKO NA
    Mitochondrial and anabolic pathways in hepatocellular carcinoma.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29559.
    PubMed     Text format    

  24. OU-YANG Q, Lin XM, Zhu YJ, Zheng B, et al
    Distinct Role of Nuclear Receptor Corepressor 1 Regulated de novo Fatty Acids Synthesis in Liver Regeneration and Hepatocarcinogenesis.
    Hepatology. 2017 Sep 28. doi: 10.1002/hep.29562.
    PubMed     Text format     Abstract available

  25. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Treatment failure with DAA in hepatocellular carcinoma: More than one explanation?
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29553.
    PubMed     Text format    

  26. CHTIOUI H
    OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29556.
    PubMed     Text format    

  27. REBOUISSOU S, Bioulac-Sage P, Nault JC, Calderaro J, et al
    Reply to << Glutamine synthetase staining and CTNNB1 mutation in hepatocellular adenomas >>.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29563.
    PubMed     Text format    

  28. RIORDAN JD, Feddersen CR, Tschida BR, Jackson P, et al
    Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29565.
    PubMed     Text format     Abstract available

  29. KAKAR S, Ferrell LD
    Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas.
    Hepatology. 2017 Sep 29. doi: 10.1002/hep.29567.
    PubMed     Text format    


    Int J Cancer

  30. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  31. GLUSHKO T, Kushchayev SV, Trifanov D, Salei A, et al
    Focal Hepatic Glycogenosis in a Patient With Uncontrolled Diabetes Mellitus Type 1.
    J Comput Assist Tomogr. 2017 Sep 20. doi: 10.1097/RCT.0000000000000673.
    PubMed     Text format     Abstract available


    J Gastroenterol

  32. SETO WK, Yuen MF
    Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    J Gastroenterol. 2017;52:164-174.
    PubMed     Text format     Abstract available

  33. CHAYAMA K, Suzuki F, Karino Y, Kawakami Y, et al
    Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
    J Gastroenterol. 2017 Sep 25. doi: 10.1007/s00535-017-1391.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  34. GILES H, Ross A, Gearry RB
    Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
    J Gastroenterol Hepatol. 2017;32:1663.
    PubMed     Text format    

  35. NGUYEN BD
    Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
    J Gastroenterol Hepatol. 2017;32:1667.
    PubMed     Text format    

  36. DING F, Li Q, Duan X, Ye J, et al
    Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
    J Gastroenterol Hepatol. 2017;32:1666.
    PubMed     Text format    

  37. NJEI B, McCarty TR, Laine L
    Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
    J Gastroenterol Hepatol. 2017;32:852-858.
    PubMed     Text format     Abstract available

  38. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
    ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    J Gastroenterol Hepatol. 2017;32:879-886.
    PubMed     Text format     Abstract available

  39. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Text format     Abstract available


    J Hepatol

  40. GANDHI CR
    Hepatic stellate cell activation and pro-fibrogenic signals.
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32068.
    PubMed     Text format    

  41. BESTE LA, Green PK, Berry K, Kogut MJ, et al
    Reply to Letters to the Editor from Mazzarelli et al. entitled "Direct-acting antiviral therapy in patients with hepatocellular cancer: the timing of treatment is everything" and Tammineedi et al. entitled "More extended indication of DAA therapy in p
    J Hepatol. 2017 Sep 19. pii: S0168-8278(17)32292.
    PubMed     Text format    


    J Pediatr Surg

  42. MITSUNAGA T, Higashimoto Y, Saito T, Iwai J, et al
    Usefulness of 99mTc-DTPA galactosyl human serum albumin liver scintigraphy for evaluating hepatic functional reserve after Kasai procedure.
    J Pediatr Surg. 2017 Sep 5. pii: S0022-3468(17)30555.
    PubMed     Text format     Abstract available


    Lancet Oncol

  43. WASAN HS, Gibbs P, Sharma NK, Taieb J, et al
    First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trial
    Lancet Oncol. 2017 Aug 3. pii: S1470-2045(17)30457.
    PubMed     Text format     Abstract available


    Oncogene

  44. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  45. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Text format     Abstract available

  46. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Text format     Abstract available

  47. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Text format     Abstract available

  48. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Text format     Abstract available


    PLoS Biol

  49. JUNEJA M, Kobelt D, Walther W, Voss C, et al
    Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.
    PLoS Biol. 2017;15:e2000784.
    PubMed     Text format     Abstract available


    PLoS One

  50. OHNO Y, Koizumi M, Nakayama H, Watanabe T, et al
    Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    PLoS One. 2017;12:e0177343.
    PubMed     Text format     Abstract available

  51. MATSUMOTO K, Ichimura M, Tsuneyama K, Moritoki Y, et al
    Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0175406.
    PubMed     Text format     Abstract available

  52. KAMIMURA K, Yokoo T, Kamimura H, Sakamaki A, et al
    Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
    PLoS One. 2017;12:e0178991.
    PubMed     Text format     Abstract available

  53. KIM HM, Kim YM, Huh JH, Lee ES, et al
    alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    PLoS One. 2017;12:e0179204.
    PubMed     Text format     Abstract available

  54. KLOTTER V, Gunchick C, Siemers E, Rath T, et al
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    PLoS One. 2017;12:e0178784.
    PubMed     Text format     Abstract available

  55. SOGABE M, Okahisa T, Nakasono M, Fukuno H, et al
    The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    PLoS One. 2017;12:e0177925.
    PubMed     Text format     Abstract available

  56. HONG M, Jung J, Park HS, Lee SM, et al
    Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways.
    PLoS One. 2017;12:e0178514.
    PubMed     Text format     Abstract available

  57. HO SW, Yeh CB, Yang SF, Yeh HW, et al
    Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study.
    PLoS One. 2017;12:e0178571.
    PubMed     Text format     Abstract available

  58. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available

  59. MASARONE M, Rosato V, Aglitti A, Bucci T, et al
    Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
    PLoS One. 2017;12:e0178473.
    PubMed     Text format     Abstract available

  60. LI M, Chen D, Huang H, Wang J, et al
    Caveolin1 protects against diet induced hepatic lipid accumulation in mice.
    PLoS One. 2017;12:e0178748.
    PubMed     Text format     Abstract available

  61. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Text format     Abstract available

  62. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    PubMed     Text format     Abstract available

  63. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    PubMed     Text format     Abstract available

  64. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    PubMed     Text format     Abstract available

  65. LI SC, Lee CH, Hung CL, Wu JC, et al
    Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
    PLoS One. 2017;12:e0182255.
    PubMed     Text format     Abstract available

  66. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Text format     Abstract available

  67. HUA MC, Su HM, Yao TC, Kuo ML, et al
    Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    PLoS One. 2017;12:e0182277.
    PubMed     Text format     Abstract available

  68. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Text format     Abstract available

  69. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    PubMed     Text format     Abstract available

  70. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    PubMed     Text format     Abstract available

  71. GOEBEL J, Sulke M, Lazik-Palm A, Goebel T, et al
    Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    PLoS One. 2017;12:e0181488.
    PubMed     Text format     Abstract available

  72. KAUFMANN B, Wang B, Zhong S, Laschinger M, et al
    BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    PLoS One. 2017;12:e0180225.
    PubMed     Text format     Abstract available

  73. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available

  74. RISSIN DM, Lopez-Longarela B, Pernagallo S, Ilyine H, et al
    Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury.
    PLoS One. 2017;12:e0179669.
    PubMed     Text format     Abstract available

  75. HAGA Y, Kanda T, Nakamura M, Nakamoto S, et al
    Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
    PLoS One. 2017;12:e0174153.
    PubMed     Text format     Abstract available


    Radiology

  76. WANG WT, Yang L, Yang ZX, Hu XX, et al
    Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.
    Radiology. 2017 Sep 22:170515. doi: 10.1148/radiol.2017170515.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: